Advanced Search

Scientific opinion on the substantiation of health claims related to Tussilago farfara L. and function of the upper respiratory tract and immune health (ID 2497) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal 2009; 7(9):1301 [12 pp.]. doi:10.2903/j.efsa.2009.1301
  EFSA Panel on Dietetic Products, Nutrition and Allergies Panel Members Jean-Louis Bresson, Albert Flynn, Marina Heinonen, Karin Hulshof, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Hildegard Przyrembel, Seppo Salminen, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Henk van den Berg, Hendrik van Loveren and Hans Verhagen Contact nda@efsa.europa.eu
Type: Opinion of the Scientific Committee/Scientific Panel On request from: European Commission Question number: EFSA-Q-2008-3230 Adopted: 02 July 2009 Published: 01 October 2009 Last updated: 25 November 2009. This version replaces the previous one/s. Affiliation: European Food Safety Authority (EFSA), Parma, Italy
Article
  • send
  • print
  • cite
Abstract

No abstract available

Summary

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to Tussilago farfara L. and normal function of the upper respiratory tract and “immune health”. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders.

The food constituent that is the subject of the health claims is Tussilago farfara L.. The Panel considers that Tussilago farfara L. has not been sufficiently characterised.

Function of the upper respiratory tract

The claimed effect is “health of the upper respiratory tract / immune health”. The Panel considers that normal function of the upper respiratory tract is beneficial to human health.

Two reference were cited to substantiate the claimed effect. These references were in Russian and an English translation was not available to the Panel. The Panel concludes that a cause and effect relationship has not been established between the consumption of Tussilago farfara L. and normal function upper respiratory tract.

Immune health

The claimed effect is “health of the upper respiratory tract / immune health”. The claimed effect “immune health” is not sufficiently defined and no more details were provided in the proposed wording. The Panel considers that “immune health” is not sufficiently defined.

Two reference were cited to substantiate the claimed effect. These references were in Russian and an English translation was not available to the Panel. The Panel concludes that a cause and effect relationship has not been established between the consumption of Tussilago farfara L. and “immune health”.

Keywords

Tussilago farfara L., immune health, respiratory tract, health claims

See also